Bruker (BRKR) Revenue (2010 - 2026)

Bruker (BRKR) has reported Revenue for 17 consecutive years, with $838.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 5.15% year-over-year to $838.5 million; the trailing twelve-month figure through Jun 2026 stood at $3.5 billion (up 1.65% YoY), and the FY2025 full-year result was $3.4 billion, up 2.08% from the prior year.
• Revenue advanced to $838.5 million in Q2 2026 per BRKR's latest filing, from $823.4 million in the prior quarter.
• Across five years, Revenue topped out at $979.6 million in Q4 2024 and bottomed at $588.4 million in Q2 2022.
• Historically, Revenue has averaged $775.6 million across 5 years, with a median of $799.0 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Revenue increased 20.62% in 2023, then fell 0.45% in 2025.
• Over 5 years, Revenue stood at $708.4 million in 2022, then climbed by 20.62% to $854.5 million in 2023, then grew by 14.64% to $979.6 million in 2024, then decreased by 0.24% to $977.2 million in 2025, then retreated by 14.19% to $838.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $838.5 million, $823.4 million, and $977.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.